MedTrace Logo

Effect of CGM on Glucose Control in Non-insulin-treated Patients with Type 2 Diabetes Mellitus

NCT06587438 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2024-09-19

No results posted yet for this study

Summary

The clinical value of CGM for diabetic patients undergoing insulin therapy has been widely recognized, but the evidence-based support for its use in non-insulin-treated type 2 diabetic patients remains insufficient. The primary objective of this study is to evaluate the effect of real-time continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose on glycemic control in adults with non-insulin treated type 2 diabetes.

Conditions

Interventions

DEVICE

Sinocare iCan I3 CGM

Real-time Continuous glucose monitoring

DEVICE

Sinocare jinzhi+Blood glucose meter

Self-monitoring of blood glucose

Sponsors & Collaborators

  • Sinocare

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-15
Primary Completion
2025-09-30
Completion
2026-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06587438 on ClinicalTrials.gov